Cambridge Investment Research Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $277K | Sell |
3,153
-236
| -7% | -$20.7K | ﹤0.01% | 3051 |
|
|
2025
Q1 | $309K | Sell |
3,389
-32
| -0.9% | -$2.92K | ﹤0.01% | 2845 |
|
|
2024
Q4 | $295K | Sell |
3,421
-40,792
| -92% | -$3.52M | ﹤0.01% | 2845 |
|
|
2024
Q3 | $4.2M | Buy |
44,213
+39,385
| +816% | +$3.74M | 0.01% | 902 |
|
|
2024
Q2 | $442K | Buy |
4,828
+1,981
| +70% | +$181K | ﹤0.01% | 2392 |
|
|
2024
Q1 | $258K | Buy |
+2,847
| New | +$258K | ﹤0.01% | 2827 |
|
|
2023
Q3 | – | Sell |
-9,802
| Closed | -$772K | – | 3238 |
|
|
2023
Q2 | $772K | Buy |
9,802
+3,228
| +49% | +$254K | ﹤0.01% | 1799 |
|
|
2023
Q1 | $510K | Sell |
6,574
-20,019
| -75% | -$1.55M | ﹤0.01% | 2063 |
|
|
2022
Q4 | $2.07M | Buy |
26,593
+23,339
| +717% | +$1.81M | 0.01% | 1061 |
|
|
2022
Q3 | $219K | Sell |
3,254
-767
| -19% | -$51.6K | ﹤0.01% | 2626 |
|
|
2022
Q2 | $309K | Buy |
+4,021
| New | +$309K | ﹤0.01% | 2359 |
|